Cellular Adaptation to VEGF-Targeted Antiangiogenic Therapy Induces Evasive Resistance by Overproduction of Alternative Endothelial Cell Growth Factors in Renal Cell Carcinoma()()

Vascular endothelial growth factor (VEGF)–targeted antiangiogenic therapy significantly inhibits the growth of clear cell renal cell carcinoma (RCC). Eventually, therapy resistance develops in even the most responsive cases, but the mechanisms of resistance remain unclear. Herein, we developed two t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neoplasia
Huvudupphovsmän: Han, Kyung Seok, Raven, Peter A., Frees, Sebastian, Gust, Kilian, Fazli, Ladan, Ettinger, Susan, Hong, Sung Joon, Kollmannsberger, Cristian, Gleave, Martin E., So, Alan I.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Neoplasia Press 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4681895/
https://ncbi.nlm.nih.gov/pubmed/26678908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2015.11.001
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk